10 pack-years of smoking: not the magic number for COPD risk and prognosis

IF 16.6 1区 医学 Q1 RESPIRATORY SYSTEM
Helena Backman
{"title":"10 pack-years of smoking: not the magic number for COPD risk and prognosis","authors":"Helena Backman","doi":"10.1183/13993003.01230-2024","DOIUrl":null,"url":null,"abstract":"<sec><st>Extract</st>\n<p>Threshold values play a critical role in clinical medicine, as they provide standardised criteria for diagnosis and treatment, ensuring consistency across different healthcare providers and settings. They help in maintaining uniformity in patient care, making sure that patients with similar characteristics receive similar evaluations and interventions. They also aid in risk stratification, allowing for targeted interventions for high-risk individuals, thereby optimising resource allocation and improving outcomes. For instance, lung function thresholds can help identify patients at risk for COPD and initiate appropriate management, such as help with smoking cessation [1]. And on the topic of thresholds and smoking, in many clinical settings across the globe, a COPD diagnosis is mainly considered in individuals with more than 10 or even 20 pack-years of smoking history, and randomised controlled trials of COPD patients most often use the 10 pack-year threshold as an inclusion criterion [2]. Tobacco use is indeed the single most preventable cause of both death and disease [3], but this 10 pack-years of smoking threshold with regards to COPD risk is, however, mainly based on tradition and not so much on solid scientific evidence.</p>\n</sec>","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":null,"pages":null},"PeriodicalIF":16.6000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Respiratory Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/13993003.01230-2024","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Extract

Threshold values play a critical role in clinical medicine, as they provide standardised criteria for diagnosis and treatment, ensuring consistency across different healthcare providers and settings. They help in maintaining uniformity in patient care, making sure that patients with similar characteristics receive similar evaluations and interventions. They also aid in risk stratification, allowing for targeted interventions for high-risk individuals, thereby optimising resource allocation and improving outcomes. For instance, lung function thresholds can help identify patients at risk for COPD and initiate appropriate management, such as help with smoking cessation [1]. And on the topic of thresholds and smoking, in many clinical settings across the globe, a COPD diagnosis is mainly considered in individuals with more than 10 or even 20 pack-years of smoking history, and randomised controlled trials of COPD patients most often use the 10 pack-year threshold as an inclusion criterion [2]. Tobacco use is indeed the single most preventable cause of both death and disease [3], but this 10 pack-years of smoking threshold with regards to COPD risk is, however, mainly based on tradition and not so much on solid scientific evidence.

吸烟 10 包年:并非慢性阻塞性肺病风险和预后的神奇数字
提取阈值在临床医学中起着至关重要的作用,因为它们为诊断和治疗提供了标准化的标准,确保了不同医疗机构和医疗环境的一致性。它们有助于保持患者护理的一致性,确保具有相似特征的患者接受相似的评估和干预。它们还有助于进行风险分层,对高风险人群进行有针对性的干预,从而优化资源分配,改善治疗效果。例如,肺功能阈值可帮助识别慢性阻塞性肺病的高危患者,并启动适当的管理,如帮助戒烟[1]。关于阈值和吸烟的话题,在全球许多临床环境中,慢性阻塞性肺病的诊断主要考虑吸烟史超过10包年甚至20包年的患者,而慢性阻塞性肺病患者的随机对照试验也通常将10包年阈值作为纳入标准[2]。烟草使用确实是导致死亡和疾病的唯一最可预防的原因[3],但这一与慢性阻塞性肺病风险有关的10包年吸烟阈值主要是基于传统,而不是基于可靠的科学证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Respiratory Journal
European Respiratory Journal 医学-呼吸系统
CiteScore
27.50
自引率
3.30%
发文量
345
审稿时长
2-4 weeks
期刊介绍: The European Respiratory Journal (ERJ) is the flagship journal of the European Respiratory Society. It has a current impact factor of 24.9. The journal covers various aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine, and thoracic surgery. In addition to original research material, the ERJ publishes editorial commentaries, reviews, short research letters, and correspondence to the editor. The articles are published continuously and collected into 12 monthly issues in two volumes per year.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信